Elizabeth M Bonachea1, Sheng-Wei Chang2, Gloria Zender2, Stephanie LaHaye3, Sara Fitzgerald-Butt4, Kim L McBride4, Vidu Garg5. 1. Department of Pediatrics, The Ohio State University, Columbus, Ohio. 2. 1] Center for Cardiovascular and Pulmonary Research, Nationwide Children's Hospital, Columbus, Ohio [2] The Heart Center, Nationwide Children's Hospital, Columbus, Ohio. 3. 1] Center for Cardiovascular and Pulmonary Research, Nationwide Children's Hospital, Columbus, Ohio [2] The Heart Center, Nationwide Children's Hospital, Columbus, Ohio [3] Department of Molecular Genetics, The Ohio State University, Columbus, Ohio. 4. 1] Department of Pediatrics, The Ohio State University, Columbus, Ohio [2] Center for Cardiovascular and Pulmonary Research, Nationwide Children's Hospital, Columbus, Ohio [3] The Heart Center, Nationwide Children's Hospital, Columbus, Ohio. 5. 1] Department of Pediatrics, The Ohio State University, Columbus, Ohio [2] Center for Cardiovascular and Pulmonary Research, Nationwide Children's Hospital, Columbus, Ohio [3] The Heart Center, Nationwide Children's Hospital, Columbus, Ohio [4] Department of Molecular Genetics, The Ohio State University, Columbus, Ohio.
Abstract
BACKGROUND: Bicuspid aortic valve (BAV) is the most common type of congenital heart disease (CHD) and has a proposed genetic etiology. BAV is categorized by cusp fusion, with right-left (R-L) cusp fusion being associated with additional CHD, and right-noncoronary cusp (R-NC) fusion being associated with aortic valve dysfunction. Loss of murine Gata5, which encodes a cardiac transcription factor, results in a partially penetrant R-NC BAV, and we hypothesize that mutations in GATA5 are associated with R-NC BAV in humans. METHODS: A cohort of 78 BAV patients (50 with isolated BAV and 28 with associated aortic coarctation) was analyzed using Sanger sequencing to identify GATA5 sequence variants. Biochemical assays were performed to identify functional deficits of identified sequence variants. RESULTS: We identified two rare heterozygous nonsynonymous variants, p.Gln3Arg and p.Leu233Pro, for a frequency of 2.6% (2/78). Both individuals with nonsynonymous variants had BAV and aortic coarctation, one R-L and one R-NC subtype. Of the nonsynonymous variants, only p.Gln3Arg demonstrated decreased transcriptional activity in vitro. CONCLUSION: Rare sequence variants in GATA5 are associated with human BAV. Our findings suggest a genotype-phenotype correlation in regards to associated CHD but not cusp fusion.
BACKGROUND:Bicuspid aortic valve (BAV) is the most common type of congenital heart disease (CHD) and has a proposed genetic etiology. BAV is categorized by cusp fusion, with right-left (R-L) cusp fusion being associated with additional CHD, and right-noncoronary cusp (R-NC) fusion being associated with aortic valve dysfunction. Loss of murineGata5, which encodes a cardiac transcription factor, results in a partially penetrant R-NC BAV, and we hypothesize that mutations in GATA5 are associated with R-NC BAV in humans. METHODS: A cohort of 78 BAV patients (50 with isolated BAV and 28 with associated aortic coarctation) was analyzed using Sanger sequencing to identify GATA5 sequence variants. Biochemical assays were performed to identify functional deficits of identified sequence variants. RESULTS: We identified two rare heterozygous nonsynonymous variants, p.Gln3Arg and p.Leu233Pro, for a frequency of 2.6% (2/78). Both individuals with nonsynonymous variants had BAV and aortic coarctation, one R-L and one R-NC subtype. Of the nonsynonymous variants, only p.Gln3Arg demonstrated decreased transcriptional activity in vitro. CONCLUSION: Rare sequence variants in GATA5 are associated with human BAV. Our findings suggest a genotype-phenotype correlation in regards to associated CHD but not cusp fusion.
Authors: Salah A Mohamed; Zouhair Aherrahrou; Henrike Liptau; Armin W Erasmi; Carolin Hagemann; Sandra Wrobel; Katja Borzym; Heribert Schunkert; Hans H Sievers; Jeanette Erdmann Journal: Biochem Biophys Res Commun Date: 2006-05-15 Impact factor: 3.575
Authors: Lisa J Martin; Vijaya Ramachandran; Linda H Cripe; Robert B Hinton; Gregor Andelfinger; Meredith Tabangin; Kerry Shooner; Mehdi Keddache; D Woodrow Benson Journal: Hum Genet Date: 2007-01-04 Impact factor: 4.132
Authors: C Biben; R Weber; S Kesteven; E Stanley; L McDonald; D A Elliott; L Barnett; F Köentgen; L Robb; M Feneley; R P Harvey Journal: Circ Res Date: 2000-11-10 Impact factor: 17.367
Authors: Bohao Chen; Elena Yates; Yong Huang; Paul Kogut; Lan Ma; Jerrold R Turner; Yun Tao; Blanca Camoretti-Mercado; Deborah Lang; Eric C Svensson; Joe G N Garcia; Peter J Gruber; Edward E Morrisey; Julian Solway Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-09-24 Impact factor: 4.052
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Maja Hempel; Teresa Casar Tena; Thilo Diehl; Martina S Burczyk; Tim M Strom; Christian Kubisch; Melanie Philipp; Davor Lessel Journal: Hum Genet Date: 2017-02-08 Impact factor: 4.132
Authors: Sara N Koenig; Stephanie LaHaye; James D Feller; Patrick Rowland; Kan N Hor; Aaron J Trask; Paul Ml Janssen; Freddy Radtke; Brenda Lilly; Vidu Garg Journal: JCI Insight Date: 2017-11-02
Authors: Katelynn A Toomer; Diana Fulmer; Lilong Guo; Alex Drohan; Neal Peterson; Paige Swanson; Brittany Brooks; Rupak Mukherjee; Simon Body; Joshua H Lipschutz; Andy Wessels; Russell A Norris Journal: Dev Dyn Date: 2017-06-28 Impact factor: 3.780
Authors: Varun K Krishnamurthy; Richard C Godby; G R Liu; J Michael Smith; Loren F Hiratzka; Daria A Narmoneva; Robert B Hinton Journal: J Cardiovasc Transl Res Date: 2014-11-20 Impact factor: 4.132